BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

934 related articles for article (PubMed ID: 15105893)

  • 21. Incidence and implications of negative serum thyroglobulin but positive I-131 whole-body scans in patients with well-differentiated thyroid cancer prepared with rhTSH or thyroid hormone withdrawal.
    Cherk MH; Francis P; Topliss DJ; Bailey M; Kalff V
    Clin Endocrinol (Oxf); 2012 May; 76(5):734-40. PubMed ID: 22050475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Importance of measurement of thyroglobulin and anti-thyroglobulin antibodies in differentiated thyroid cancer.
    Alagić-Smailbegović J; Kucukalić-Selimović E; Setić I; Bećirović M; Begović L
    Coll Antropol; 2012 Nov; 36 Suppl 2():33-8. PubMed ID: 23397752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The value of a new IRMA for determining thyroglobulin].
    Heinze HG; Rall M
    Nuklearmedizin; 1992 Oct; 31(5):172-7. PubMed ID: 1465354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Impact of Detectable Antithyroglobulin Antibodies Below the Reference Limit (Borderline) in Patients with Papillary Thyroid Carcinoma with Undetectable Serum Thyroglobulin and Normal Neck Ultrasonography After Ablation: A Prospective Study.
    Côrtes MCS; Rosario PW; Oliveira LFF; Calsolari MR
    Thyroid; 2018 Feb; 28(2):229-235. PubMed ID: 29325506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment for microcarcinoma of the thyroid--clinical experience.
    Küçük NO; Tari P; Tokmak E; Aras G
    Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of thyroglobulin antibody epitopes in differentiated thyroid cancer.
    Lupoli GA; Okosieme OE; Evans C; Clark PM; Pickett AJ; Premawardhana LD; Lupoli G; Lazarus JH
    J Clin Endocrinol Metab; 2015 Jan; 100(1):100-8. PubMed ID: 25322272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neck recurrence from thyroid carcinoma: serum thyroglobulin and high-dose total body scan are not reliable criteria for cure after radioiodine treatment.
    Bachelot A; Leboulleux S; Baudin E; Hartl DM; Caillou B; Travagli JP; Schlumberger M
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):376-9. PubMed ID: 15730423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma.
    Spencer CA; Takeuchi M; Kazarosyan M; Wang CC; Guttler RB; Singer PA; Fatemi S; LoPresti JS; Nicoloff JT
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1121-7. PubMed ID: 9543128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical meaning of circulating antithyroglobulin antibodies in differentiated thyroid cancer: a prospective study.
    Rubello D; Casara D; Girelli ME; Piccolo M; Busnardo B
    J Nucl Med; 1992 Aug; 33(8):1478-80. PubMed ID: 1634938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Influence of endogenous TgAb upon serum Tg measurement results and Tg positive rate in patients with differentiated thyroid carcinoma].
    Zhang W; Deng H; Pan M; Huang R; Tang G
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2013 Aug; 30(4):803-7. PubMed ID: 24059060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness of the combined antithyroglobulin antibodies and thyroglobulin assay in the follow-up of patients with differentiated thyroid cancer.
    Rubello D; Girelli ME; Casara D; Piccolo M; Perin A; Busnardo B
    J Endocrinol Invest; 1990 Oct; 13(9):737-42. PubMed ID: 2292657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thyroglobulin before ablation and correlation with posttreatment scanning.
    de Rosário PW; Guimarães VC; Maia FF; Fagundes TA; Purisch S; Padrao EL; Rezende LL; Barroso AL
    Laryngoscope; 2005 Feb; 115(2):264-7. PubMed ID: 15689747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The value of serum thyroglobulin determination in the after-care of patients with differentiated thyroid neoplasms].
    Hüfner M; Pollmann H; Grussendorf M; Schenk P
    Schweiz Med Wochenschr; 1980 Feb; 110(5):159-62. PubMed ID: 7361086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic value of serum thyroglobulin measurements in the follow-up of differentiated thyroid carcinoma, a structured meta-analysis.
    Eustatia-Rutten CF; Smit JW; Romijn JA; van der Kleij-Corssmit EP; Pereira AM; Stokkel MP; Kievit J
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):61-74. PubMed ID: 15212646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical relevance of highly sensitive Tg assay in monitoring patients treated for differentiated thyroid cancer.
    Iervasi A; Iervasi G; Ferdeghini M; Solimeo C; Bottoni A; Rossi L; Colato C; Zucchelli GC
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):434-41. PubMed ID: 17555505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An evaluation of the value of first thyroglobulin determination in the diagnostics of metastases immediately following differentiated thyroid carcinoma surgery.
    Makarewicz J; Adamczewski Z; Rutkowski A; Mikosiński S; Knapska-Kucharska M; Gonerska-Szadkowska A; Oszukowska L; Karwowska A; Lewiński A
    Endokrynol Pol; 2006; 57(4):370-3. PubMed ID: 17006838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Value of the assay of thyroglobulin for postoperative surveillance of differentiated thyroid cancers].
    Jaffiol C; Baldet L
    Ann Med Interne (Paris); 1984; 135(5):359-64. PubMed ID: 6486615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of Low Levels of Thyroglobulin Autoantibodies Associated with Undetectable Thyroglobulin After Thyroidectomy for Differentiated Thyroid Carcinoma.
    Latrofa F; Ricci D; Sisti E; Piaggi P; Nencetti C; Marinò M; Vitti P
    Thyroid; 2016 Jun; 26(6):798-806. PubMed ID: 27020734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thyroglobulin: current aspects of its role in autoimmune thyroid disease and thyroid cancer.
    Okosieme OE; Parkes AB; Premawardhana LD; Evans C; Lazarus JH
    Minerva Med; 2003 Oct; 94(5):319-30. PubMed ID: 14973426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Change of serum antithyroglobulin antibody levels is useful for prediction of clinical recurrence in thyroglobulin-negative patients with differentiated thyroid carcinoma.
    Kim WG; Yoon JH; Kim WB; Kim TY; Kim EY; Kim JM; Ryu JS; Gong G; Hong SJ; Shong YK
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4683-9. PubMed ID: 18812478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.